期刊文献+

Capsule enteroscopy is useful for the therapeutic management of Crohn's disease 被引量:1

下载PDF
导出
摘要 AIM: To analyze therapeutic changes in Crohn's disease(CD) patients following video capsule endoscopy(VCE) and to assess the usefulness of Lewis score and the Patency Capsule.METHODS: Patency Capsule was performed in every patient that had indication for VCE, and those with negative patency did not undergo VCE. Patients with established CD that underwent VCE between January 2011 and February 2014 were selected for this study; those with suspected CD were excluded, independent of VCE results, since our purpose was to address differences in therapeutic regimen in CD patients before and after VCE. Patients with inconclusive VCE were also excluded. Patients had to be free of non-steroidal anti-inflammatories for at least 1 mo. Those patients who met these criteria were allocated into one of three groups: Staging group(asymptomatic CD patients that underwent VCE for staging of CD), Flare group(patients with active CD), or Post-op group(CD patients evaluated for post-operative recurrence). Lewis score was calculated for every VCE procedure. Statisticalanalysis was performed to address the impact of VCE findings on the therapeutic management of CD patients and to evaluate the utility of the Lewis score.RESULTS: From a total of 542 VCEs, 135 were performed in patients with CD. Patency capsule excluded nearly 25% of the patients who were supposed to undergo VCE. No videocapsule retention during VCE was reported. From these 135 patients, 29 were excluded because CD diagnosis was not established at the time of VCE. Therefore, a total of 106 patients were included in the final analysis. From these, the majority were in the Staging group(n = 73, 69%), and the remaining were in the Flare(n = 23, 22%) or Post-op(n = 10, 9%) group. Median time between diagnosis and VCE was 5.5 years. Overall, VCE determined changes in the treatment of 40% of patients: only 21% remained free of immunosuppressors after VCE compared to 44% before VCE(P < 0.001). The differences in therapy before and after VCE achieved statistical significance in the Staging and Flare groups. In addition, patients were significantly different when stratified regarding time since diagnosis to the date of VCE. A higher Lewis score was associated with therapeutic modifications(P < 0.0001); where a score higher than 1354 was related to 90% probability of changing therapy [area under the receiver operative characteristic(AUROC) 0.80(95%CI: 0.69-0.88)]. CONCLUSION: VCE significantly changed the therapeutic management of CD patients, even in those with long-term disease. Systematic use of Patency capsule allowed for no videocapsule retention. AIM: To analyze therapeutic changes in Crohn’s disease(CD) patients following video capsule endoscopy(VCE) and to assess the usefulness of Lewis score and the Patency Capsule.METHODS: Patency Capsule was performed in every patient that had indication for VCE, and those with negative patency did not undergo VCE. Patients with established CD that underwent VCE between January 2011 and February 2014 were selected for this study; those with suspected CD were excluded, independent of VCE results, since our purpose was to address differences in therapeutic regimen in CD patients before and after VCE. Patients with inconclusive VCE were also excluded. Patients had to be free of non-steroidal anti-inflammatories for at least 1 mo. Those patients who met these criteria were allocated into one of three groups: Staging group(asymptomatic CD patients that underwent VCE for staging of CD), Flare group(patients with active CD), or Post-op group(CD patients evaluated for post-operative recurrence). Lewis score was calculated for every VCE procedure. Statisticalanalysis was performed to address the impact of VCE findings on the therapeutic management of CD patients and to evaluate the utility of the Lewis score.RESULTS: From a total of 542 VCEs, 135 were performed in patients with CD. Patency capsule excluded nearly 25% of the patients who were supposed to undergo VCE. No videocapsule retention during VCE was reported. From these 135 patients, 29 were excluded because CD diagnosis was not established at the time of VCE. Therefore, a total of 106 patients were included in the final analysis. From these, the majority were in the Staging group(n = 73, 69%), and the remaining were in the Flare(n = 23, 22%) or Post-op(n = 10, 9%) group. Median time between diagnosis and VCE was 5.5 years. Overall, VCE determined changes in the treatment of 40% of patients: only 21% remained free of immunosuppressors after VCE compared to 44% before VCE(P < 0.001). The differences in therapy before and after VCE achieved statistical significance in the Staging and Flare groups. In addition, patients were significantly different when stratified regarding time since diagnosis to the date of VCE. A higher Lewis score was associated with therapeutic modifications(P < 0.0001); where a score higher than 1354 was related to 90% probability of changing therapy [area under the receiver operative characteristic(AUROC) 0.80(95%CI: 0.69-0.88)]. CONCLUSION: VCE significantly changed the therapeutic management of CD patients, even in those with long-term disease. Systematic use of Patency capsule allowed for no videocapsule retention.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第44期12660-12666,共7页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献20

  • 1Marco Pennazio,Cristiano Spada,Rami Eliakim,Martin Keuchel,Andrea May,Chris Mulder,Emanuele Rondonotti,Samuel Adler,Joerg Albert,Peter Baltes,Federico Barbaro,Christophe Cellier,Jean Charton,Michel Delvaux,Edward Despott,Dirk Domagk,Amir Klein,Mark McAlindon,Bruno Rosa,Georgina Rowse,David Sanders,Jean Saurin,Reena Sidhu,Jean-Marc Dumonceau,Cesare Hassan,Ian Gralnek.Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline[J]. Endoscopy . 2015 (04)
  • 2José Cotter,Francisca Dias de Castro,Joana Magalh?es,Maria Moreira,Bruno Rosa.Validation of the Lewis score for the evaluation of small-bowel Crohn’s disease activity[J]. Endoscopy . 2015
  • 3Barry Hall,Grainne Holleran,Deirdre McNamara.Current applications and potential future role of wireless capsule technology in Crohn’s disease[J]. Scandinavian Journal of Gastroenterology . 2014 (11)
  • 4Barry Hall,Grainne Holleran,Jun-Liong Chin,Sinead Smith,Barbara Ryan,Nasir Mahmud,Deirdre McNamara.A prospective 52<ce:hsp sp="0.25"/>week mucosal healing assessment of small bowel Crohn’s disease as detected by capsule endoscopy[J]. Journal of Crohn’s and Colitis . 2014
  • 5José Cotter,Francisca Dias de Castro,Maria Jo?o Moreira,Bruno Rosa.Tailoring Crohn’s disease treatment: The impact of small bowel capsule endoscopy[J]. Journal of Crohn’s and Colitis . 2014
  • 6Catherine Dussault,Corinne Gower-Rousseau,Julia Salleron,Gwénola Vernier-Massouille,Julien Branche,Jean-Frédéric Colombel,Vincent Maunoury.Small bowel capsule endoscopy for management of Crohn’s disease: A retrospective tertiary care centre experience[J].Digestive and Liver Disease.2013(7)
  • 7Vito Annese,Marco Daperno,Matthew D. Rutter,Aurelien Amiot,Peter Bossuyt,James East,Marc Ferrante,Martin G?tz,Konstantinos H. Katsanos,Ralf Kie?lich,Ingrid Ordás,Alessandro Repici,Bruno Rosa,Shaji Sebastian,Torsten Kucharzik,Rami Eliakim.European evidence based consensus for endoscopy in inflammatory bowel disease[J].Journal of Crohn’s and Colitis.2013(12)
  • 8Diagnostic Accuracy of Capsule Endoscopy for Small Bowel Crohn’s Disease Is Superior to That of MR Enterography or CT Enterography[J]. Clinical Gastroenterology and Hepatology . 2011 (2)
  • 9Glen A. Doherty,Alan C. Moss,Adam S. Cheifetz.Capsule endoscopy for small-bowel evaluation in Crohn’s disease[J]. Gastrointestinal Endoscopy . 2011 (1)
  • 10Shahab Mehdizadeh,Gary C. Chen,Linda Barkodar,Pedram J. Enayati,Shahriar Pirouz,Michael Yadegari,Andrew Ippoliti,Eric A. Vasiliauskas,Simon K. Lo,Konstantinos Antonios Papadakis.Capsule endoscopy in patients with Crohn’s disease: diagnostic yield and safety[J]. Gastrointestinal Endoscopy . 2010 (1)

共引文献11

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部